METASTATIC PANCREATIC NEUROENDOCRINE TUMOR
Clinical trials for METASTATIC PANCREATIC NEUROENDOCRINE TUMOR explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PANCREATIC NEUROENDOCRINE TUMOR trials appear
Sign up with your email to follow new studies for METASTATIC PANCREATIC NEUROENDOCRINE TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising combo therapy for rare pancreatic cancer enters human trials
Disease control Recruiting nowThis early-phase trial tests whether combining two targeted drugs—sunitinib malate and lutetium Lu 177 dotatate (Lutathera)—is safe and effective for people with advanced pancreatic neuroendocrine tumors. The study enrolls 24 adults whose tumors have spread or cannot be removed. …
Matched conditions: METASTATIC PANCREATIC NEUROENDOCRINE TUMOR
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 09:55 UTC
-
New combo therapy aims to shrink hard-to-treat pancreatic tumors
Disease control Recruiting nowThis early-stage study tests whether adding fulvestrant to standard radiation therapy (Lu-DOTATATE) can better control advanced pancreatic neuroendocrine tumors. About 25 adults with tumors that cannot be surgically removed will receive the combination. The main goals are to chec…
Matched conditions: METASTATIC PANCREATIC NEUROENDOCRINE TUMOR
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated May 26, 2026 09:51 UTC